EMERGENCE AND MANAGEMENT OF DISEASE BURDEN OF MRSA; A REVIEW FOR THE GLOBAL CHALLENGES

  • Research Scientist-I Department of Microbiology, Gulbarga Institute of Medical Sciences (GIMS), Kalaburagi-585105, Karnataka, India.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • How to Cite This Article
  • Corresponding Author

MRSA is a major human pathogen responsible for wide spectrum of diseases, prefers to grown pH environment above 6.5.They can survive down to pH 5 for extended periods of time. However the limits of endurance can be stretched if the organisms are first adapted to moderate acid pH or any antibiotic stress. MRSA is one of the major resistant pathogen found in the much members and skin of around one third of the population. It is extremely adaptable to antibiotic pressure. MRSA is associated with a number of virulence factors, Over half a century; the medical practitioner?s gas relied on the antibiotics to treat many pyogenic infections as well as other diseases. Unfortunately the misuse, overdose and overuse of antibiotics have triggered an increasing quality, variety and proliferation of multi-drug resistant (super bug). And consequently particularly virulent strain of MRSA these virulence strain gas developed resistant to all types of antibiotics including the last resort vancomycine. Now this natural ability of bacteria to develop resistant has become alarming health concern. Alternative method of treating of these antibiotic resistant staphylococcus infections are current being explored. This study helps in knowing theoretical problems associated with the resistant organism and leads to the development of new drug or any antibiotic or inhibitors which counteracts MRSA infections. It is possible to use in the human being also as a Therapeutic agents.

  1. Anupurbha S, Sen G, Nath BM, Sharma AK, Gulati and Mohapatra M. 2003. Prevalence of MRSA in a tertiary referral hospital in Eastern Uttar Pradesh. J. Med. Microbiology 21: 49-51.
  2. Ananthanarayan R and Jayaram CK. 1996. Text book of microbiology. 5th Orient Longman.
  3. Boyce JM, CXausly WA. 1982. Increasing occurrence of MRSA in United States, inf. Control 3: 377-383.
  4. Chambers HF. 1997. Methicillin resistant aureus; Molecular and Biochemical basis and clinical implications. Clin. Microbial Rev.10: 781-791
  5. Boyce TM. 1990. Increasing prevalence of MRSA in the united state. Infected control of hosp. Epidemoit11: 639-642.
  6. Voss C, Eyol E, Frank M, Von der Lieth CW, Berger 2006. FASEB J. 20:1194-11.
  7. Chamber HF. 2001. The changing epidemiology of aureus. Emergence Infections. Dis.7: 178-182.
  8. Chambers HF.1997. Methicillin resistant aureus; Molecular and Biochemical basis and clinical implications. Clin. Microbial Rev. 10: 781-791.
  9. Livemore DM. 2000. Antibiotic resistant in staphylococci. j. Antimicrob. Agent 16: S3-S4.
  10. Ritz M, Tholozan JL, Fedirighi M, Pilet MF. 2001. Morphological; and physiological characterization of Listeria monocytogenessubjected to high hydrostatic pressure. Environ.Microbiol. 67: 2240-2247.
  11. Lewis K. 1994. Multidrug resistant pumps in bacteria: Variations on a theme Trends Biochem. Sci. 19:119-123.
  12. Conrad RS, Howard MJ, Garrison RC, winters S, Henderson D. 1998. The effect of daptomycin on chemical composition and morphology of Staphylococcus aureus. Proc. Okla. Acad Sci.78: 15-22.
  13. Heipieper HJ, Weber FJ, Sikkim J. Keweloah H, de Bont JA. 1994. Mechanism behind resistance of whole cells to toxic organic solvents. Trends Biotechnol.12: 409-415.
  14. Paul F, Cleark, Ruehl WH. 1919. Morphological changes during the growth of bacteria, medical school, university of wiscon, maldiso. An electron microscopic study of glycopeptides antibiotic-resistant strain of staphylococcus epidermis. J.Med. Micro. 39: 204-210.
  15. Aldsworth TG, Sharman RL, Dodd CE. 1999. Bacterial suicide through stress. Cell Mol. Life. Sci. 56: 378-383.
  16. Desousa MA, Sanches IS, Ferro ML, Vaz MJ, Saraiva Z, Tendeiro T, Serra J and de Lancaster H. 1998. Intercontinental spread of multidrug resistant Methicillin resistant Staphylococcus aureus J. clin. Microbial.36: 2590-2596.
  17. Lanzarini F. 1990. Effect of teicoplanin and vancomycin on staphylococcus aureus.Ultra structure. Microbiol. 13: 231-237.
  18. Krishnan PU, Miles M and Shetty N. 2002. Detection of Methicillin and mypirocin resistant in Staphylococcus aureus isolates using conventional and molecular method a descriptive study from a burn unit with a high prevalence of MRSA, Clin. Pathol. 55: 745-748.
  19. Sulakvelidze A. 2001. Bacteriophage therapy, Minireview. AgentsChemother. 45: 649?659
  20. Kutter EB. 2001. Bacteriophage as natural, self replicating and self limiting antibiotics. Astrazeneca research foundation India.
  21. Escribano I. 2006. Relation between induction of the mar operon and cyclohexane tolerance and reduction in fluoroquinolone susceptibility in Salmonella spp. Infect. Chemother. 12: 177-180

Prabhurajeshwar C. (2018); EMERGENCE AND MANAGEMENT OF DISEASE BURDEN OF MRSA; A REVIEW FOR THE GLOBAL CHALLENGES, Int. J. of Adv. Res., 6 (11), 843-847, ISSN 2320-5407. DOI URL: https://dx.doi.org/10.21474/IJAR01/8069

Prabhurajeshwar C
Research Scientist-I

DOI:

Article DOI: 10.21474/IJAR01/8069      
DOI URL: https://dx.doi.org/10.21474/IJAR01/8069

Download Full Paper

Download PDF No. of Downloads: 6 | No. of Views: 41